Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Product sales, net $ 3,954 $ 3,966 $ 7,956 $ 8,114
Cost of goods sold 2,094 2,248 4,243 4,614
Gross profit 1,860 1,718 3,713 3,500
Operating expenses:        
Research and development 28 36 64 71
Selling, general and administrative 2,415 2,758 4,852 4,914
Benefit from reversal of accrued payroll taxes (Note 12) 0 0 0 (6,171)
 Total operating expenses 2,443 2,794 4,916 (1,186)
Operating income (loss) (583) (1,076) (1,203) 4,686
Other expense, net 1 209 3 265
Income (loss) before income taxes (584) (1,285) (1,206) 4,421
Income tax expense 0 3 6 3
Net income (loss) $ (584) $ (1,288) $ (1,212) $ 4,418
Weighted average common shares outstanding, basic (in shares) 172,418 152,599 167,823 152,353
Weighted average common shares outstanding, diluted (in shares) 172,418 152,599 167,823 152,353
Net income (loss) per common share, basic (in USD per share) $ (0) $ (0.01) $ (0.01) $ 0.03
Net income (loss) per common share, basic diluted (in USD per share) $ (0) $ (0.01) $ (0.01) $ 0.03
Revenue, product and service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember